FIELD: biotechnology; chemistry.
SUBSTANCE: invention relates to biology, chemistry and biotechnology. Disclosed is use of compound of 8-hydroxy-10-((2R,3R,4S)-2,3,4,5-tetrahydroxypentyl)pyrimido[4,5-b]quinoline-2,4(3H,10H)-dione and/or its sulphated analogue (2S,3R,4R)-1,2,4-trihydroxy-5-(8-hydroxy-2,4-dioxo-3,4-dihydropyrimido[4,5-b]quinolin-10(2H)-yl)pentane-3-ylhydrosulphate or a pharmaceutically acceptable salt thereof as a component of a bioluminescent reaction in a biological sample, also containing luciferase or nucleic acid coding luciferase, and luciferin of the worm of Henlea sp.
EFFECT: wider range of technical means in the field of using bioluminescent systems.
6 cl, 13 dwg, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD AND REAGENTS FOR DETECTING LUCIFERASE ACTIVITY | 2020 |
|
RU2826202C2 |
METHOD AND REAGENTS FOR DETECTING LUCIFERASE ACTIVITY | 2019 |
|
RU2744869C2 |
MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | 2014 |
|
RU2678327C2 |
METHOD OF OBTAINING PHOTOSENSITIZER FOR PHOTODYNAMIC DESTRUCTION OF TUMOR CELLS | 2023 |
|
RU2807293C1 |
MEDICINAL COMPOUNDS | 2014 |
|
RU2691105C1 |
SECONDARY MANNOSIS FOR BACTERIAL INFECTIONS TREATMENT | 2013 |
|
RU2667060C2 |
PHOTOSENSITIZER FOR PHOTODYNAMIC DESTRUCTION OF TUMOR CELLS | 2023 |
|
RU2805148C1 |
METHOD AND REAGENTS FOR DETECTION OF LUCIFERASE ACTIVITY | 2015 |
|
RU2596398C1 |
PRODRUG OF POLYMERASE NS5B HCV INHIBITOR, METHOD FOR ITS PREPARATION AND APPLICATION | 2017 |
|
RU2644156C1 |
ANTIVIRAL COMPOSITION AND METHOD OF ITS APPLICATION | 2017 |
|
RU2650610C1 |
Authors
Dates
2024-11-25—Published
2020-07-08—Filed